Assessment of the usefulness of performing bacterial identification and antimicrobial susceptibility testing 24 h a day in a clinical microbiology laboratory 

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors  S. Amit, H. Mishali, T. Kotlovsky,
R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T
Clinical impact of a real-time PCR assay for rapid identification of Staphylococcus aureus and determination of methicillin resistance from positive blood.
G. Cornaglia, A. Lönnroth, M. Struelens 
Gut bacterial microbiota and obesity
M.A.C. Broeren, Y. Maas, E. Retera, N.L.A. Arents 
Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience  H. Asgeirsson, A. Thalme, M. Kristjansson,
In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin- resistant Acinetobacter baumannii  X. Vila-Farres, C. Garcia.
Evolution of extended-spectrum β-lactamases by mutation
Extended-spectrum and CMY-type b-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain  Y.
Use of a multiplex PCR-based reverse line blot (mPCR/RLB) hybridisation assay for the rapid identification of bacterial pathogens  Y. Wang, F. Kong, G.L.
Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints  L. Jakobsen, D. Sandvang, V.F. Jensen, A.M.
Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?  M. Paul, N. Zemer-Wassercug, O.
Is the prevalence of antibiotic-resistant organisms changing in Canadian hospitals? Comparison of point-prevalence survey results in 2010 and 2012  V.
Appropriate vs. inappropriate antimicrobial therapy
W. Witte, B. Pasemann, C. Cuny  Clinical Microbiology and Infection 
A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals  M. Nagao  Clinical Microbiology and.
H. Adibhesami, M. Douraghi, M. Rahbar, A. Abdollahi 
Vector control: a cornerstone in the malaria elimination campaign
Pharmacodynamics of doxycycline
The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System  M.E.A. de Kraker, V. Jarlier,
Training for the infectious diseases speciality in Norway
G. Höffken  Clinical Microbiology and Infection 
Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia  S.-C. Kuo, Y.-T. Lee,
Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals  C. Nonhoff, O. Denis,
Secular trends of bloodstream infections during neutropenia in 15 181 haematopoietic stem cell transplants: 13-year results from a European multicentre.
Laboratory diagnosis and biosafety issues of biological warfare agents
Bacterial resistance—the clinical challenge
Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin- clavulanate and piperacillin-tazobactam with extended-spectrum.
Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria  Inga Odenholt, Elisabeth Löwdin,
G. Kronvall  Clinical Microbiology and Infection 
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Four-year epidemiological study of extended-spectrum β-lactamase-producing Enterobacteriaceae in a French teaching hospital  L. Gibold, F. Robin, R.-N.
Metagenomics and probiotics
J. Buijs, A. S. M. Dofferhoff, J. W. Mouton, J. H. T. Wagenvoort, J. W
O. Murillo, I. Grau, J. Lora-Tamayo, J. Gomez-Junyent, A. Ribera, F
Risk factors for extended-spectrum β-lactamase-producing Escherichia coli urinary tract infection in the community in Denmark: a case–control study  M.
Laboratory diagnosis of Clostridium difficile disease
Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases  L. Romero, L. López,
Pandemic lineages of extraintestinal pathogenic Escherichia coli
A.W. Karchmer  Clinical Microbiology and Infection 
Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS (T-3811) tested against non-fermentative Gram-negative bacilli  W.
P.M. Hawkey  Clinical Microbiology and Infection 
Evolving problems with resistant pathogens
Correlation between clinical data and antibiotic resistance in coagulase-negative Staphylococcus species isolated from 68 patients with acute post-cataract.
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
Prevalence and diversity of extended-spectrum ß-lactamases in faecal Escherichia coli isolates from healthy humans in Spain  L. Vinué, Y. Sáenz, S. Martínez,
Catheter-related bloodstream infection caused by Enterococcus spp.
Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit  S. Nseir, C. Blazejewski, R. Lubret,
G.M. Rossolini, E. Mantengoli  Clinical Microbiology and Infection 
R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T
P. Kaltsas, S. Want, J. Cohen  Clinical Microbiology and Infection 
Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting  A. Kronenberg, S. Koenig, S. Droz,
Predominance of SHV-5 β-lactamase in enteric bacteria causing community-acquired urinary tract infections in Bosnia and Herzegovina  S. Uzunovic-Kamberovic,
Abstracts Clinical Microbiology and Infection
New oral cephalosporins in pediatric community-acquired infections
J. Wilson, S. Elgohari, D. M. Livermore, B. Cookson, A. Johnson, T
A. Manzur, F. Gudiol  Clinical Microbiology and Infection 
Antibiotic overconsumption and resistance in Turkey
B.A. Cunha  Clinical Microbiology and Infection 
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Impact of a targeted isolation strategy at intensive-care-unit-admission on intensive- care-unit-acquired infection related to multidrug-resistant bacteria:
J. Segreti  Clinical Microbiology and Infection 
Figure 1. Rates of IEAT and AEAT in most common microorganisms causing inappropriate treatment. Abbreviations: AEAT, ... Figure 1. Rates of IEAT and AEAT.
The future of diagnostic bacteriology
Secular trends of bloodstream infections during neutropenia in 15 181 haematopoietic stem cell transplants: 13-year results from a European multicentre.
Presentation transcript:

Assessment of the usefulness of performing bacterial identification and antimicrobial susceptibility testing 24 h a day in a clinical microbiology laboratory  M. Eveillard, C. Lemarié, J. Cottin, H. Hitoto, C. Mahaza, M. Kempf, M.-L. Joly-Guillou  Clinical Microbiology and Infection  Volume 16, Issue 8, Pages 1084-1089 (August 2010) DOI: 10.1111/j.1469-0691.2009.03044.x Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Initiation of appropriate treatment 48 h earlier for bacteraemia due to extended-spectrum β-lactamase (ESBL)-producing Escherichia coli. Clinical Microbiology and Infection 2010 16, 1084-1089DOI: (10.1111/j.1469-0691.2009.03044.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Microorganisms (Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter baumannii and Enterococcus faecalis) involved in the benefit of early appropriate antimicrobial treatment provided by the night service (n = 97) CNS, coagulase-negative staphylococci. Clinical Microbiology and Infection 2010 16, 1084-1089DOI: (10.1111/j.1469-0691.2009.03044.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 3 Antimicrobial agents avoided because of the night service. Clinical Microbiology and Infection 2010 16, 1084-1089DOI: (10.1111/j.1469-0691.2009.03044.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions